Sigal Charles Elliott

Number of records: 14
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
03-Jun-24 12:18 PM
View: 
Vir Biotechnology, Inc. (VIR) 30-May-24Grant 8,000----31%
25.81K to 33.81K
08-Sep-23 4:00 PM
View: 
Surface Oncology, Inc. (SURF) 08-Sep-23Disposition 45,453----(100%)
45.45K to 0
24-May-23 2:33 PM
View: 
Vir Biotechnology, Inc. (VIR) 22-May-23Grant 6,027----30%
19.78K to 25.81K
02-Mar-23 4:27 PM
View: 
Vir Biotechnology, Inc. (VIR) 01-Mar-23Private Purchase (Planned) 2,500$22.73$56,815.5014%
17.28K to 19.78K
09-Jan-23 11:51 AM
View: 
Vir Biotechnology, Inc. (VIR) 05-Jan-23Private Purchase (Planned) 2,500$24.96$62,395.5017%
14.78K to 17.28K
05-Jan-23 5:00 PM
View: 
Vir Biotechnology, Inc. (VIR) 04-Jan-23Purchase (Planned) 2,500$25.25$63,136.2020%
12.28K to 14.78K
05-Jan-23 5:00 PM
View: 
Vir Biotechnology, Inc. (VIR) 03-Jan-23Private Purchase (Planned) 2,500$25.60$63,992.5026%
9.78K to 12.28K
25-May-22 6:09 PM
View: 
Vir Biotechnology, Inc. (VIR) 23-May-22Grant 6,405----190%
3.37K to 9.78K
25-May-21 4:48 PM
View: 
Vir Biotechnology, Inc. (VIR) 21-May-21Grant 3,374----100%
0 to 3.37K
23-Apr-18 4:15 PM
View: 
Surface Oncology, Inc. (SURF) 23-Apr-18Conversion 45,453----100%
0 to 45.45K
19-May-16 4:47 PM
View: 
Adaptimmune Therapeutics plc (ADAP) 19-May-16Private Purchase 15,000$1.56$23,400.004%
352.04K to 367.04K
18-May-16 7:34 PM
View: 
Adaptimmune Therapeutics plc (ADAP) 18-May-16Private Purchase 15,000$1.55$23,250.004%
337.04K to 352.04K
18-May-16 7:34 PM
View: 
Adaptimmune Therapeutics plc (ADAP) 17-May-16Private Purchase 15,000$1.53$22,950.005%
322.04K to 337.04K
18-May-16 7:34 PM
View: 
Adaptimmune Therapeutics plc (ADAP) 16-May-16Private Purchase 15,000$1.50$22,500.005%
307.04K to 322.04K